Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • OUTLOOK

Will the reclassification of multiple myeloma change how people are treated?

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 587, S56-S57 (2020)

doi: https://doi.org/10.1038/d41586-020-03224-1

This article is part of Nature Outlook: Multiple myeloma, an editorially independent supplement produced with the financial support of third parties. About this content.

References

  1. Kuehl, W. M. & Bergsagel, P. L. J. Clin. Invest. 122, 3456–3463 (2012).

    Article  PubMed  Google Scholar 

  2. Kumar, S. et al. J. Clin. Oncol. 38, 8509 (2020).

    Article  Google Scholar 

  3. Corre, J. et al. Haematologica https://doi.org/10.3324/haematol.2019.236588 (2020).

    Article  Google Scholar 

  4. Kristinsson, S. Y., Anderson, W. F. & Landgren, O. Leukemia 28, 1346–1348 (2014).

    Article  PubMed  Google Scholar 

  5. Jiménez, C. et al. J. Mol. Diagnost. 19, 99–106 (2017).

    Article  Google Scholar 

  6. D’Agostino, M. & Raje, N. Leukemia 34, 21–34 (2020).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links